Is Jaguar Health Inc. (JAGX) a Keeper? – News Heater

Is Jaguar Health Inc. (JAGX) a Keeper?

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Jaguar Health Inc. (NASDAQ:JAGX) went down by -2.65% from its latest closing price compared to the recent 1-year high of $4.47. The company’s stock price has collected -10.91% of loss in the last five trading sessions. Press Release reported on 04/29/21 that Jaguar Health and Napo Pharmaceuticals Announce Title of Abstract Regarding Patient Outcomes Associated with Cancer Therapy-Related Diarrhea Accepted for Poster Presentation at the American Society of Clinical Oncology 2021 Annual Meeting

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Is It Worth Investing in Jaguar Health Inc. (NASDAQ :JAGX) Right Now?

Plus, the 36-month beta value for JAGX is at 1.50. Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for Jaguar Health Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!


The average price from analysts is $4.50. JAGX currently public float of 127.39M and currently shorts hold a 4.25% ratio of that float. Today, the average trading volume of JAGX was 11.94M shares.

JAGX’s Market Performance

JAGX stocks went down by -10.91% for the week, with a monthly drop of -25.76% and a quarterly performance of -47.87%, while its annual performance rate touched 219.57%. The volatility ratio for the week stands at 9.10% while the volatility levels for the past 30 days are set at 10.41% for Jaguar Health Inc.. The simple moving average for the period of the last 20 days is -9.29% for JAGX stocks with a simple moving average of 23.56% for the last 200 days.

Analysts’ Opinion of JAGX

Many brokerage firms have already submitted their reports for JAGX stocks, with Rodman & Renshaw repeating the rating for JAGX by listing it as a “Buy.” The predicted price for JAGX in the upcoming period, according to Rodman & Renshaw is $2 based on the research report published on July 11th of the previous year 2017.

JAGX Trading at -22.21% from the 50-Day Moving Average

After a stumble in the market that brought JAGX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -67.11% of loss for the given period.

Volatility was left at 10.41%, however, over the last 30 days, the volatility rate increased by 9.10%, as shares sank -26.13% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -48.60% lower at present.

During the last 5 trading sessions, JAGX fell by -10.91%, which changed the moving average for the period of 200-days by +111.18% in comparison to the 20-day moving average, which settled at $1.5945. In addition, Jaguar Health Inc. saw 80.37% in overturn over a single year, with a tendency to cut further gains.

Stock Fundamentals for JAGX

Current profitability levels for the company are sitting at:

  • -283.93 for the present operating margin
  • +65.05 for the gross margin

The net margin for Jaguar Health Inc. stands at -360.25. The total capital return value is set at -86.59, while invested capital returns managed to touch -133.52. Equity return is now at value -623.70, with -103.10 for asset returns.

Based on Jaguar Health Inc. (JAGX), the company’s capital structure generated 94.23 points at debt to equity in total, while total debt to capital is 48.52. Total debt to assets is 37.84, with long-term debt to equity ratio resting at 72.21. Finally, the long-term debt to capital ratio is 37.18.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

When we switch over and look at the enterprise to sales, we see a ratio of 4.22, with the company’s debt to enterprise value settled at 0.41. The receivables turnover for the company is 3.00 and the total asset turnover is 0.24. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.35.

Sign up for our FREE Newsletter and get:

Leave a Comment

Your email address will not be published. Required fields are marked *

Sign up for our FREE Newsletter and get:

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Important Earnings

Insider Watchlist

We do not sell or share your information with anyone.